Tinavi Medical Stock Hits Day Low of CNY 18.77 Amid Price Pressure

Tinavi Medical Technologies Co., Ltd. experienced a notable decline in its stock performance on June 18, 2026, with a decrease of 5.51%. The stock reached an intraday low of CNY 18.77, reflecting the company's ongoing challenges in the competitive pharmaceuticals and biotechnology sector. Despite a strong year-to-date performance of 24.23%, the company's recent results indicate a struggle with profitability, as evidenced by a negative operating profit margin of -89.45% and a pre-tax profit of CNY -53.81 million for the latest quarter. Over the past five years, Tinavi has faced a decline in operating profit at an annual rate of -10.80%, while net sales have grown at a modest rate of 13.49%. The company's market capitalization stands at CNY 5,690 million, categorizing it as a mid-cap entity. However, with a return on equity of -20.41% and a price-to-book ratio of 4.92, Tinavi Medical Technologies is navigating a challenging financial landscape. The stock's performance contrasts with the China Shanghai Composite, which saw a minor decline of 0.43% on the same day.